- Home
- EVN vs DNA Comparison
EVN vs DNA Comparison
Compare EVN & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVN
- DNA
- Stock Information
- Founded
- EVN 1998
- DNA 2008
- Country
- EVN United States
- DNA United States
- Employees
- EVN N/A
- DNA N/A
- Industry
- EVN Investment Bankers/Brokers/Service
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EVN Finance
- DNA Health Care
- Exchange
- EVN Nasdaq
- DNA Nasdaq
- Market Cap
- EVN 410.0M
- DNA 466.4M
- IPO Year
- EVN N/A
- DNA N/A
- Fundamental
- Price
- EVN $10.37
- DNA $12.69
- Analyst Decision
- EVN
- DNA Sell
- Analyst Count
- EVN 0
- DNA 3
- Target Price
- EVN N/A
- DNA $9.67
- AVG Volume (30 Days)
- EVN 101.2K
- DNA 1.6M
- Earning Date
- EVN 01-01-0001
- DNA 08-07-2025
- Dividend Yield
- EVN 4.78%
- DNA N/A
- EPS Growth
- EVN N/A
- DNA N/A
- EPS
- EVN 0.34
- DNA N/A
- Revenue
- EVN N/A
- DNA $237,417,000.00
- Revenue This Year
- EVN N/A
- DNA N/A
- Revenue Next Year
- EVN N/A
- DNA $15.81
- P/E Ratio
- EVN $29.94
- DNA N/A
- Revenue Growth
- EVN N/A
- DNA 13.76
- 52 Week Low
- EVN $8.64
- DNA $5.00
- 52 Week High
- EVN $10.45
- DNA $16.85
- Technical
- Relative Strength Index (RSI)
- EVN 61.22
- DNA 79.41
- Support Level
- EVN $10.23
- DNA $8.21
- Resistance Level
- EVN $10.27
- DNA $10.02
- Average True Range (ATR)
- EVN 0.06
- DNA 0.87
- MACD
- EVN 0.02
- DNA 0.39
- Stochastic Oscillator
- EVN 73.08
- DNA 88.09
About EVN Eaton Vance Municipal Income Trust
Eaton Vance Municipal Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax. The trust's portfolio of investments majorly consists of debt instruments of governments, municipal organizations the interest on which is exempt from regular federal income tax and has also some exposure to corporate bonds and other instruments.
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.